HomeNewsBusinessMax Life chief hopes Axis Bank to complete Rs 1,612-cr capital infusion in 3 months

Max Life chief hopes Axis Bank to complete Rs 1,612-cr capital infusion in 3 months

Axis Bank board on August 9 gave its nod to Rs 1,612-crore infusion in Max Life Insurance Company Limited, a material subsidiary of Max Financial Services Limited

February 14, 2024 / 11:22 IST
Story continues below Advertisement
Prashant Tripathy, MD and CEO, Max Life Insurance
Prashant Tripathy, MD and CEO, Max Life Insurance

New Delhi-based Max Life Insurance is looking at the completion of a Rs 1,612-crore capital infusion of by Axis Bank into the company in the next three months, Managing Director and Chief Executive Officer Prashant Tripathy said in an interaction with Moneycontrol on February 14.

"Insurance regulator Insurance Regulatory and Development Authority of India (IRDAI) has given the green light for this infusion, only CCI (Competition Commission Of India) approval is pending, which we are expecting in the next three months," Tripathy said.

Story continues below Advertisement

The Axis Bank board on August 9 gave its nod to the Rs 1,612-crore infusion in Max Life Insurance Company Limited, a material subsidiary of Max Financial Services Limited. The bank said the Acquisitions, Divestments, and Merger Committee has approved the proposal for the infusion through preferential allotment.

The proposed acquisition, the bank said, would strengthen its position in the life insurance business. After completion of this acquisition, it will increase the total holding of the bank (along with its subsidiaries e.g. Axis Securities Ltd. and Axis Capital Ltd) in Max Life from 12.99 percent to 19.02 percent, Axis Bank informed stock exchanges.